Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Nature Communications
|
August 30, 2020
Sex differences in oncogenic mutational processes
Constance H Li, Stephenie D Prokopec, Ren X Sun, et al.
BMC Genomics
|
August 21, 2015
Male and female mice show significant differences in hepatic transcriptomic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin
Jamie Lee, Stephenie D Prokopec, John D Watson, et al.
Toxicology and Applied Pharmacology
|
August 2, 2015
Transcriptional profiling of rat white adipose tissue response to 2,3,7,8-tetrachlorodibenzo-ρ-dioxin
Kathleen E Houlahan, Stephenie D Prokopec, Ren X Sun, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
May 1, 2020
Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics and Drug Response
Seungil Kim, Sarah Choung, Ren X Sun, et al.
Cancers
|
June 3, 2020
Anti-EGFR Therapy Induces EGF Secretion by Cancer-Associated Fibroblasts to Confer Colorectal Cancer Chemoresistance
Colleen M Garvey, Roy Lau, Alyssa Sanchez, et al.
Iscience
|
June 11, 2021
Human colorectal cancer-on-chip model to study the microenvironmental influence on early metastatic spread
Carly Strelez, Sujatha Chilakala, Kimya Ghaffarian, et al.
Journal of Translational Medicine
|
March 9, 2016
PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma
Yael Babichev, Leah Kabaroff, Alessandro Datti, et al.
International Journal of Cancer
|
November 24, 2018
A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth
Kara M Ruicci, Jalna Meens, Ren X Sun, et al.
BMC Genomics
|
December 4, 2014
Cross-species transcriptomic analysis elucidates constitutive aryl hydrocarbon receptor activity
Ren X Sun, Lauren C Chong, Trent T Simmons, et al.
The Journal of Clinical Investigation
|
February 9, 2021
Inhibition of relaxin autocrine signaling confers therapeutic vulnerability in ovarian cancer
Helen E Burston, Oliver A Kent, Laudine Communal, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Nature Communications
|
August 30, 2020
Sex differences in oncogenic mutational processes
Constance H Li, Stephenie D Prokopec, Ren X Sun, et al.
BMC Genomics
|
August 21, 2015
Male and female mice show significant differences in hepatic transcriptomic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin
Jamie Lee, Stephenie D Prokopec, John D Watson, et al.
Toxicology and Applied Pharmacology
|
August 2, 2015
Transcriptional profiling of rat white adipose tissue response to 2,3,7,8-tetrachlorodibenzo-ρ-dioxin
Kathleen E Houlahan, Stephenie D Prokopec, Ren X Sun, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
May 1, 2020
Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics and Drug Response
Seungil Kim, Sarah Choung, Ren X Sun, et al.
Cancers
|
June 3, 2020
Anti-EGFR Therapy Induces EGF Secretion by Cancer-Associated Fibroblasts to Confer Colorectal Cancer Chemoresistance
Colleen M Garvey, Roy Lau, Alyssa Sanchez, et al.
Iscience
|
June 11, 2021
Human colorectal cancer-on-chip model to study the microenvironmental influence on early metastatic spread
Carly Strelez, Sujatha Chilakala, Kimya Ghaffarian, et al.
Journal of Translational Medicine
|
March 9, 2016
PI3K/AKT/mTOR inhibition in combination with doxorubicin is an effective therapy for leiomyosarcoma
Yael Babichev, Leah Kabaroff, Alessandro Datti, et al.
International Journal of Cancer
|
November 24, 2018
A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth
Kara M Ruicci, Jalna Meens, Ren X Sun, et al.
BMC Genomics
|
December 4, 2014
Cross-species transcriptomic analysis elucidates constitutive aryl hydrocarbon receptor activity
Ren X Sun, Lauren C Chong, Trent T Simmons, et al.
The Journal of Clinical Investigation
|
February 9, 2021
Inhibition of relaxin autocrine signaling confers therapeutic vulnerability in ovarian cancer
Helen E Burston, Oliver A Kent, Laudine Communal, et al.
Page
of 2